Acadia Pharmaceuticals Inc (ACAD): Revenue
$1.07B
Year ended 2025-12-31
$1.14B
Trailing 12 months to 2026-06-30
+27.5%
3-year compound annual growth
+19.4%
5-year compound annual growth
n/m
10-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.07B | +11.9% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $957.80M | +31.8% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $726.44M | +40.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $517.24M | +6.8% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $484.14M | +9.6% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $441.75M | +30.3% | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | $339.08M | +51.5% | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | $223.81M | +79.2% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $124.90M | +620.7% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $17.33M | n/m | 2019-02-27, From 2016-01-01 |
| 2015-12-31 | $61.0K | -49.2% | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | $120.0K | -89.5% | 2017-02-28, From 2014-01-01 |
| 2013-12-31 | $1.15M | -76.7% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $4.91M | +137.4% | 2015-02-26, From 2012-01-01 |
| 2011-12-31 | $2.07M | -95.1% | 2014-02-27, From 2011-01-01 |
| 2010-12-31 | $42.13M | +558.5% | 2013-03-12, From 2010-01-01 |
| 2009-12-31 | $6.40M | n/a | 2012-03-06, From 2009-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $1.07B | +11.9% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $1.09B | -4.3% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $958.40M | +432.1% |
| Ionis Pharmaceuticals Inc (IONS) | 2025-12-31 | $943.71M | +33.8% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $1.24B | +4.3% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $883.37M | +43.8% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $868.45M | +21.5% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $829.45M | n/m |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $780.57M | +23.6% |
Compare ACAD, PBH, MDGL, IONS side by side · Screen every company in Pharmaceutical Preparations ↗